Hemoglobin A, Glycosylated
Research News and Information

Sunday, November 08, 2009

The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial.

24 Oct 2009 BACKGROUND: Although African American adults bear a disproportionate burden from diabetes mellitus (DM), few randomized controlled trials have tested culturally appropriate interventions to improve DM care. METHODS: We randomly assigned 542 African ... Read more...

Three-year efficacy of complex insulin regimens in type 2 diabetes.

20 Oct 2009 BACKGROUND: Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes mellitus is limited. METHODS: In this 3-year open-label, multicenter trial, we evaluated 708 patients who had suboptimal ... Read more...

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

11 Oct 2009 OBJECTIVES: This study was designed to evaluate myocardial substrate and high-energy phosphate (HEP) metabolism in asymptomatic men with well-controlled, uncomplicated type 2 diabetes with verified absence of cardiac ischemia, and age-matched ... Read more...

Latest indexed articles for 'Hemoglobin A, Glycosylated'

These are the very latest articles for this heading:

• The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. 24 Oct 2009
• Three-year efficacy of complex insulin regimens in type 2 diabetes. 20 Oct 2009
• Optimal insulin treatment in type 2 diabetes. 20 Oct 2009
• Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. 11 Oct 2009
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. 10 Oct 2009
• The diabetes mellitus medication choice decision aid: a randomized trial. 26 Sep 2009
• Patient-centered care: what is the best measuring stick? 26 Sep 2009
• Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. 17 Sep 2009
• Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. 14 Sep 2009
• Controlling the complications of diabetes: it's about the sugar. 13 Sep 2009
• The effects of a commercially available weight loss program among obese patients with type 2 diabetes: a randomized study. 30 Aug 2009
• Defining the importance of daily glycemic control and implications for type 2 diabetes management. 30 Aug 2009
• Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes. 30 Aug 2009
• Structured patient education: the X-PERT Programme. 30 Aug 2009
• The effects of an incentive program on quality of care in diabetes management. 30 Aug 2009
• Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. 30 Aug 2009
• Efficacy and safety of incretin based therapies: clinical trial data. 30 Aug 2009
• Diabetes study findings: what do they mean? 30 Aug 2009
• Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. 30 Aug 2009
• [Intensive glucose control in type 2 diabetes is beneficial] 30 Aug 2009

See a longer list of these articles.

Technical information about 'Hemoglobin A, Glycosylated'

Definition: Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.

Registry Number: 0

Descriptor UI: D006442

Alternative terms: Hemoglobin A, Glycosylated; Hb A1a+b; Hb A1c; HbA1; Glycosylated Hemoglobin A; Hb A1; Glycohemoglobin A; Hemoglobin A(1); Hemoglobin, Glycosylated A1b; A1b Hemoglobin, Glycosylated; Glycosylated A1b Hemoglobin; Hb A1b; Hemoglobin, Glycosylated A1a-1; A1a-1 Hemoglobin, Glycosylated; Glycosylated A1a-1 Hemoglobin; Hemoglobin, Glycosylated A1a 1; Hb A1a-1; Hb A1a-2; Hemoglobin, Glycosylated; Glycosylated Hemoglobin; Glycated Hemoglobins; Hemoglobins, Glycated;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D09.408.375; D12.776.124.400.405.440; D12.776.422.316.762.380.440;

History Note: 82

Technical Notes: urine: coord IM with HEMOGLOBINURIA (IM); DF: note short X refs